NasdaqGS:FLDM

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. More Details


Snowflake Analysis

Excellent balance sheet and overvalued.


Similar Companies

Share Price & News

How has Fluidigm's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: FLDM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: FLDM's weekly volatility has decreased from 19% to 11% over the past year.


Market Performance


7 Day Return

-3.6%

FLDM

0.8%

US Life Sciences

0.6%

US Market


1 Year Return

52.3%

FLDM

45.0%

US Life Sciences

21.0%

US Market

Return vs Industry: FLDM exceeded the US Life Sciences industry which returned 45% over the past year.

Return vs Market: FLDM exceeded the US Market which returned 21% over the past year.


Shareholder returns

FLDMIndustryMarket
7 Day-3.6%0.8%0.6%
30 Day-10.8%7.4%4.2%
90 Day-11.6%13.6%12.4%
1 Year52.3%52.3%45.2%45.0%23.7%21.0%
3 Year-7.3%-7.3%110.7%109.4%47.4%37.6%
5 Year-8.7%-8.7%234.3%230.1%131.6%105.9%

Long-Term Price Volatility Vs. Market

How volatile is Fluidigm's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Fluidigm undervalued compared to its fair value and its price relative to the market?

2.91x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate FLDM's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate FLDM's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: FLDM is unprofitable, so we can't compare its PE Ratio to the US Life Sciences industry average.

PE vs Market: FLDM is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FLDM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FLDM is good value based on its PB Ratio (2.9x) compared to the US Life Sciences industry average (8.5x).


Next Steps

Future Growth

How is Fluidigm forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

14.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: FLDM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: FLDM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: FLDM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: FLDM's revenue (12.8% per year) is forecast to grow faster than the US market (10.2% per year).

High Growth Revenue: FLDM's revenue (12.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: FLDM's Return on Equity is forecast to be low in 3 years time (9.3%).


Next Steps

Past Performance

How has Fluidigm performed over the past 5 years?

1.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FLDM is currently unprofitable.

Growing Profit Margin: FLDM is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: FLDM is unprofitable, but has reduced losses over the past 5 years at a rate of 1.3% per year.

Accelerating Growth: Unable to compare FLDM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FLDM is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (30.4%).


Return on Equity

High ROE: FLDM has a negative Return on Equity (-31.37%), as it is currently unprofitable.


Next Steps

Financial Health

How is Fluidigm's financial position?


Financial Position Analysis

Short Term Liabilities: FLDM's short term assets ($122.7M) exceed its short term liabilities ($42.8M).

Long Term Liabilities: FLDM's short term assets ($122.7M) do not cover its long term liabilities ($128.2M).


Debt to Equity History and Analysis

Debt Level: FLDM's debt to equity ratio (35.6%) is considered satisfactory.

Reducing Debt: FLDM's debt to equity ratio has reduced from 157.8% to 35.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FLDM has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: FLDM has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 6.2% each year


Next Steps

Dividend

What is Fluidigm current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate FLDM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate FLDM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FLDM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FLDM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of FLDM's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Chris Linthwaite (47 yo)

4.25yrs

Tenure

US$3,713,055

Compensation

Mr. Stephen Christopher Linthwaite, also known as Chris, has been the President of Fluidigm Corporation since August 4, 2016. Mr. Linthwaite has been the Chief Executive Officer of Fluidigm Corporation si...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD3.71M) is above average for companies of similar size in the US market ($USD1.65M).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Stephen Linthwaite
President4.25yrsUS$3.71m0.20%
$ 867.7k
Vikram Jog
Chief Financial Officer12.92yrsUS$1.39m0.16%
$ 703.7k
Bradley Kreger
Senior Vice President of Global Operations2.75yrsUS$1.35m0.040%
$ 178.6k
Nicholas Khadder
Senior VP4.58yrsUS$1.26m0.068%
$ 302.5k
Colin McCracken
Chief Commercial Officer1.83yrsUS$1.96m0.027%
$ 119.9k
Stephen Quake
Co-Founder & Chairman of Advisory Boardno datano datano data
Andrew Quong
Chief Science Officer1.58yrsno datano data
Agnes Lee
Vice President of Investor Relationsno datano datano data
Mark Spearman
Senior Director of Corporate Communicationsno datano datano data
Angela Peters
Chief Human Resources Officer3.5yrsno datano data
Mai Yow
MD of Fluidigm Singapore Pte Ltd & EVP of Worldwide Manufacturing - Fluidigm Singapore Pte Ltd14.83yrsUS$748.30kno data
Ana Petrovic
Director of Corporate & Strategic Financeno datano datano data

4.3yrs

Average Tenure

47yo

Average Age

Experienced Management: FLDM's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephen Linthwaite
President4.25yrsUS$3.71m0.20%
$ 867.7k
Stephen Quake
Co-Founder & Chairman of Advisory Boardno datano datano data
Samuel Colella
Independent Director20.5yrsUS$200.46k0.30%
$ 1.3m
Gerhard Burbach
Independent Director8yrsUS$164.47k0.011%
$ 47.7k
Frank McCormick
Member of Advisory Board14.08yrsno datano data
Richard Zare
Member of Advisory Board20.08yrsno datano data
Howard Shapiro
Member of Advisory Board21.08yrsno datano data
James Berger
Member of Advisory Board18.58yrsno datano data
Laura Clague
Independent Director2.25yrsUS$153.47k0%
$ 0
Carlos Paya
Independent Chairman of the Board0.58yrUS$153.96k0.058%
$ 258.8k
Bill Colston
Independent Director1.5yrsUS$131.31kno data
Nicholas Barthelemy
Independent Director3.83yrsUS$163.22k0.19%
$ 838.3k

8.0yrs

Average Tenure

59.5yo

Average Age

Experienced Board: FLDM's board of directors are considered experienced (8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.


Top Shareholders

Company Information

Fluidigm Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Fluidigm Corporation
  • Ticker: FLDM
  • Exchange: NasdaqGS
  • Founded: 1999
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$442.490m
  • Shares outstanding: 74.12m
  • Website: https://www.fluidigm.com

Number of Employees


Location

  • Fluidigm Corporation
  • 2 Tower Place
  • Suite 2000
  • South San Francisco
  • California
  • 94080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
FLDMNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDFeb 2011
FLBDB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2011

Biography

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system,...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/15 00:57
End of Day Share Price2021/01/14 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.